Claudin18.2

CARsgen Therapeutics, Claudin18.2, Moderna, mRNA cancer vaccine, CT041, CAR-T therapy

CARsgen and Moderna Join Forces to Explore Synergy Between CT041 and mRNA Cancer Vaccine

Anika Sharma

CARsgen Therapeutics has set the stage for an intriguing partnership with Moderna that’s bound to heat up the cancer therapy ...